Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14472 | TPP | 1/1 | 3 years, 1 month ago 18 January 2023 08:41:04 UTC | View, Job request 14472 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14468 | TPP | 1/1 | 3 years, 1 month ago 17 January 2023 23:49:42 UTC | View, Job request 14468 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14467 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 23:30:23 UTC | View, Job request 14467 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14466 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 23:14:04 UTC | View, Job request 14466 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14465 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 23:07:55 UTC | View, Job request 14465 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14464 | TPP | 1/1 | 3 years, 1 month ago 17 January 2023 23:06:00 UTC | View, Job request 14464 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14463 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 23:04:09 UTC | View, Job request 14463 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14462 | TPP | 1/1 | 3 years, 1 month ago 17 January 2023 23:03:28 UTC | View, Job request 14462 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14461 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 23:00:53 UTC | View, Job request 14461 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14460 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 22:57:39 UTC | View, Job request 14460 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14459 | TPP | 0/1 | 3 years, 1 month ago 17 January 2023 22:55:47 UTC | View, Job request 14459 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14382 | TPP | 1/1 | 3 years, 1 month ago 13 January 2023 08:45:33 UTC | View, Job request 14382 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14379 | TPP | 0/1 | 3 years, 1 month ago 13 January 2023 00:20:37 UTC | View, Job request 14379 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14377 | TPP | 1/1 | 3 years, 1 month ago 13 January 2023 00:15:44 UTC | View, Job request 14377 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14375 | TPP | 1/1 | 3 years, 1 month ago 12 January 2023 21:20:41 UTC | View, Job request 14375 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14225 | TPP | 2/2 | 3 years, 2 months ago 04 January 2023 22:15:30 UTC | View, Job request 14225 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14212 | TPP | 2/2 | 3 years, 2 months ago 04 January 2023 11:59:23 UTC | View, Job request 14212 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14211 | TPP | 2/2 | 3 years, 2 months ago 04 January 2023 10:39:48 UTC | View, Job request 14211 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14210 | TPP | 2/2 | 3 years, 2 months ago 04 January 2023 10:09:15 UTC | View, Job request 14210 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14208 | TPP | 2/2 | 3 years, 2 months ago 03 January 2023 23:01:59 UTC | View, Job request 14208 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14207 | TPP | 0/2 | 3 years, 2 months ago 03 January 2023 22:56:52 UTC | View, Job request 14207 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14206 | TPP | 2/2 | 3 years, 2 months ago 03 January 2023 22:49:17 UTC | View, Job request 14206 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14204 | TPP | 2/2 | 3 years, 2 months ago 03 January 2023 22:16:19 UTC | View, Job request 14204 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14203 | TPP | 1/1 | 3 years, 2 months ago 03 January 2023 18:54:47 UTC | View, Job request 14203 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14202 | TPP | 2/2 | 3 years, 2 months ago 03 January 2023 18:08:32 UTC | View, Job request 14202 |